Suppr超能文献

分析胶质母细胞瘤患者围手术期血糖状态和地塞米松使用与术后并发症的关系。

Characterization of perioperative glycemic status and dexamethasone use with associated postoperative complications in glioblastoma patients.

机构信息

Faculty of Medicine, McGill University, Montreal, Canada.

Department of Neurology and Neurosurgery, Montreal Neurological Institute - McGill University Health Centre, Montreal, Canada.

出版信息

Acta Neurochir (Wien). 2023 Apr;165(4):1031-1040. doi: 10.1007/s00701-023-05541-6. Epub 2023 Mar 6.

Abstract

PURPOSE

Postoperative morbidity in glioblastoma (GBM) patients can be due to the disease course but can also come from postoperative complications. Our objective was to study the association of dexamethasone use and perioperative hyperglycemia with postoperative complications in GBM patients.

METHODS

A single-center, retrospective cohort study was conducted in patients who underwent surgery for primary GBM from 2014-2018. Patients with perioperative fasting blood glucose (FBG) measurements and adequate follow-up to assess for complications were included.

RESULTS

A total of 199 patients were included. More than half (53%) had poor perioperative glycemic control (FBG ≥ 7 mM for ≥ 20% perioperative days). Higher dexamethasone dose (≥ 8 mg) was associated with higher FBG on postoperative days 2-4 and 5 (p = 0.02,0.05,0.004,0.02, respectively). Poor glycemic control was associated with increased odds of 30-day any complication and 30-day infection on univariate analysis (UVA), and 30-day any complication and increased length of stay (LOS) on multivariate analysis (MVA). Higher average perioperative daily dexamethasone dose was associated with increased odds of 30-day any complication and 30-day infection on MVA. Elevated hemoglobin A1c (HgbA1c, ≥ 6.5%) was associated with increased odds of 30-day any complication, 30-day infection, and LOS on UVA. In a multivariate linear regression model, only the diagnosis of diabetes mellitus predicted perioperative hyperglycemia.

CONCLUSIONS

Perioperative hyperglycemia, higher average dexamethasone use and elevated preoperative HgbA1c are associated with increased risk of postoperative complications in GBM patients. Avoiding hyperglycemia and limiting dexamethasone use in postoperative period may decrease the risk of complications. Select HgbA1c screening may allow the identification of a group of patients at higher risk of complications.

摘要

目的

胶质母细胞瘤(GBM)患者术后发病率可能与疾病过程有关,但也可能来自术后并发症。我们的目的是研究地塞米松的使用和围手术期高血糖与 GBM 患者术后并发症的关系。

方法

对 2014 年至 2018 年间接受原发性 GBM 手术的患者进行了单中心回顾性队列研究。纳入了有围手术期空腹血糖(FBG)测量值和足够随访以评估并发症的患者。

结果

共纳入 199 例患者。超过一半(53%)患者的围手术期血糖控制不佳(FBG≥7mmol/L 超过 20%的围手术期天数)。较高的地塞米松剂量(≥8mg)与术后第 2-4 天和第 5 天的 FBG 升高相关(p=0.02、0.05、0.004、0.02,分别)。围手术期血糖控制不佳与 30 天内任何并发症和 30 天内感染的发生风险增加有关(UVA),并且与 30 天内任何并发症和住院时间延长(LOS)有关(MVA)。较高的平均围手术期地塞米松日剂量与 30 天内任何并发症和 30 天内感染的发生风险增加有关(MVA)。糖化血红蛋白(HgbA1c,≥6.5%)升高与 UVA 下的 30 天内任何并发症、30 天内感染和 LOS 风险增加有关。在多元线性回归模型中,只有糖尿病的诊断预测了围手术期高血糖。

结论

围手术期高血糖、较高的地塞米松平均使用量和术前 HgbA1c 升高与 GBM 患者术后并发症风险增加有关。避免高血糖和限制术后地塞米松使用可能会降低并发症的风险。选择 HgbA1c 筛查可能会识别出一组并发症风险较高的患者。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验